Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans ...
Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...
Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...
Study offers promise of greater comfort for current CPAP users and a better option for the roughly half of obstructive sleep apnea patients who refuse or abandon CPAP MURFREESBORO, Tenn., Oct. 8, 2024 ...
Experts say that if the new drug gets approved, it may lead to a big shift in how we treat the condition. By Caroline Hopkins Legaspi Tens of millions of people in the United States struggle with ...
SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Resmed (RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the publication of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results